ArticleOncoTargets and therapy2021

Establishment of a Risk Signature Based on m6A RNA Methylation Regulators That Predicts Poor Prognosis in Renal Cell Carcinoma.

Jingsun Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.